PubMed Health⌕ Search

Biomedical subjects

Steven E Eckert

Publications and source records attributed to Steven E Eckert.

24 records · Page 2Linked to original sources
PubMedDate not supplied

Comparison of dental implant systems: quality of clinical evidence and prediction of 5-year survival.

PURPOSE: This literature review was conducted to evaluate the quality of current evidence of clinical performance provided by American Dental Association-certified dental implant manufacturers and manufacturers with strong market penetration in the United States. The study also compared the clinical performance of different dental implant systems. MATERIALS AND METHODS: A letter was sent to 6 implant manufacturers requesting 10 references each that validated the manufacturer's implant system in a variety of clinical applications. References were reviewed and classified relative to strength of evidence. Data extraction was then performed. Comparisons of implant survival data from 5-year studies were made, and data were pooled to establish an overall 5-year survival rate with confidence intervals (CIs). RESULTS: A total of 69 references were provided by the 6 implant manufacturers (Astra Tech, Centerpulse, Dentsply/Friadent, Implant Innovations, Nobel Biocare, and Straumann) but only 59 articles were available for review. Of those references, most were level-4 (case series) or level-5 (expert opinion) articles. Five-year survival data were extracted from 17 articles demonstrating overlap of CIs from the weighted average of the pooled data from each specific manufacturer; substantial equivalence of all implant systems was demonstrated based upon survival alone at 5 years. When all data were pooled, the 5-year survival rate of 96% (CI: 93% to 98%) was observed for a total of 7,398 implants. DISCUSSION: No obvious differences in implant survival were observed when comparing implant systems. CONCLUSIONS: The evidence supporting implant therapy is generally derived from level-4 case series rather than higher-level cohort or controlled clinical trials. Articles that directly compared different implant systems were not found. Five-year implant survival rates easily exceeded the minimums recommended by the American Dental Association certification program. (More than 50 references.)

Bibliometrics↗
PubMedDate not supplied

Influence of platelet-rich plasma added to xenogeneic bone grafts on bone mineral density associated with dental implants.

PURPOSE: The purpose of this study was to assess the bone mineral density changes after bone regeneration therapy using xenogeneic demineralized freeze-dried bone graft (DFDBG) plus platelet-rich plasma (PRP) and DFDBG alone in 3-wall peri-implant defects in dogs. MATERIALS AND METHODS: The mandibular premolars and molars of 9 adult hound dogs were removed surgically, and 90 sites were prepared for implant placement. Before implant placement, a total of 162 mesial and distal 3-wall peri-implant defects were surgically created. Defects were randomly assigned to three groups: DFDBG + PRP, DFDBG alone, and no treatment. Animals were sacrificed at 1, 2, and 3 months, and specimens were subjected to bone mineral density (BMD) and bone mineral content (BMC) analysis with a peripheral dual x-ray absorptiometry densitometer. RESULTS: The effect of treatment on BMD and BMC differed significantly by month of sacrifice (P = .030 and P = .035 for the month-by-treatment interactions, respectively). BMD differed significantly between peri-implant defects treated with DFDBG alone and untreated defects at 3 months (mean BMD of 0.6667 for DFDBG alone versus 0.5606 for untreated defects; P < .001). BMC also differed significantly between peri-implant defects treated with DFDBG alone and untreated defects at 3 months (mean BMC of 0.0276 for DFDBG alone versus 0.0236 for untreated defects; P = .001). No other pairwise comparison of the treatments within each month of sacrifice or at the overall treatment effect across all three months demonstrated significant differences. DISCUSSION: PRP has been proposed as an autogenous source of growth factors, which may increase the speed and completeness of healing. This study did not demonstrate a significant improvement in BMD or BMC when PRP was combined with DFDBG. Defects where grafting material was used, either with or without PRP, did demonstrate slightly greater BMD and BMC than those left untreated. CONCLUSION: This study found that the addition of PRP to xenogeneic bone grafts did not significantly alter BMD or graft maturity levels in this animal model.

Absorptiometry, Photon↗
PubMedDate not supplied

Retrospective multicenter cohort study of the clinical performance of 2-stage implants in South Korean populations.

PURPOSE: To evaluate long-term follow-up clinical performance of dental implants in use in South Korean populations. MATERIALS AND METHODS: A retrospective multicenter cohort study design was used to collect long-term follow-up clinical data from dental records of 224 patients treated with 767 2-stage endosseous implants at Ajou University Medical Center and Bundang Jesaeng Hospital in South Korea from June 1996 through December 2003. Exposure variables such as gender, systemic disease, location, implant length, implant diameter, prosthesis type, opposing occlusion type, and date of implant placement were collected. Outcome variables such as date of implant failure were measured. RESULTS: Patient ages ranged from 17 to 71.7 years old (mean age, 45.6 years old). Implants were more frequently placed in men than in women (61% versus 39%, or 471 men versus 296 women). Systemic disease was described by 9% of the patients. All implants had hydroxyapatite-blasted surfaces. Most of the implants were 3.75 mm in diameter. Implant lengths 10 mm, 11.5 mm, 13 mm, and 15 mm were used most often. Differences of implant survival among different implant locations were observed. Implants were used to support fixed partial dentures for the majority of the restorations. The opposing dentition was natural teeth for about 50% of the implants. A survival rate of 97.9% (751 of 767) was observed after 4.5 years (mean, 1.95 +/- 1.2 years). CONCLUSION: Clinical performance of 2-stage dental implants demonstrated a high level of predictability. The results achieved with a South Korean population did not differ from results achieved with diverse ethnic groups.

Adolescent↗